Ann: Letter to Shareholders, page-110

Biotron has been rolling a ball-game of comounds showing activity since 200x.
Biotron's Mice test, ..., other tests in third party Scipps' hands may take time, and by that time, they will be in the comfort zone " results show ..."
Slow and steady wins the race, but in Biotron's case too slow to be counted in the modern time, let alone business!
Biotron needs to solve current generation problem without exaggerating too much about next-gen drag. Next-gen is X-gen where X are the numbers even unknown to MM et al. Until any news about any acquistion or partnership news, Biotron is nothing but a naliless tiger sketched in a paper ....

Stay Safe!